In the spring of 1987, nearly 350 individuals gathered in a hotel in Bethesda, Maryland, just outside of Washington, D. C. , to participate in a two-day medical symposium devoted to the topic of liver diseases. A small minority of this group had been attracted by what promised to be an outstanding Continuing Medical Education course. The remainder, however, although obviously interested in the content of the symposium, had come primarily to honor a man who, over the years, had profoundly touched them, personally or professionally, for the course had been conceived as a tribute to an exceptional man of medicine, a man with remarkable scholarly and personal attributes: Hyman J. Zimmerman. Dr. Zimmerman, referred to affectionately by all as Hy, was born in 1914 in Rochester, New York, the city in which he received both his early schooling and his undergraduate education. In the late 1930s, he moved to Palo Alto to begin his medical education at Stanford University, from which he graduated cum laude in 1942, having spent an additional year acquiring a masters degree and as World War II in bacteriology. Almost immediately thereafter, he entered military service, was in progress, was assigned to duty in France. Soon after his arrival, he was made chief of an Army field hospital. A major medical problem plaguing U. S. troops at the time was viral hepatitis, which resulted in a deluge of patients admitted to his hospital.

A timely collection of scientific & clinical information on Hepatitis C. A bound compilation of issues 1 and 2 of Seminars in Liver Disease, 2000. A hardbound compendium of Volume 20, Numbers 1 and 2 of the journal, Seminars in Liver Disease, this new volume brings together an international group of distinguished authors to present 16 current, incisive reviews and analyses of both the basic science and clinical aspects of HCV. The volume examines the broadest spectrum of HCV virology, pathology, and disease while focusing on the following key issues: HCV's impact on human populations The manifestations of the virus & its distribution throughout the body HCV molecular virology with an emphasis on its clinical implications Identification of pharmaceutical targets and vaccine components and an analysis of genotypes and interferon sensitivity In addition, the volume examines the clinical consequences of HCV infection, including immune response to HCV, B-cell abnormalities, diagnostic tests, kinetic studies, interferon-ribavirin combination therapy, liver transplantation, and vaccine development.